HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Previous close
$2.06
Day range
$2.00 - $2.27
Year range
$1.79 - $23.30
Market cap
96.37M USD
Avg Volume
297.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.36M | 145.80% |
Net income | -37.49M | -81.40% |
Net profit margin | — | — |
Earnings per share | -0.88 | 98.84% |
EBITDA | -43.52M | -105.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 285.98M | 396.98% |
Total assets | 304.64M | 305.14% |
Total liabilities | 38.06M | 46.28% |
Total equity | 266.59M | — |
Shares outstanding | 43.21M | — |
Price to book | 0.33 | — |
Return on assets | -34.05% | — |
Return on capital | -37.36% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -37.49M | -81.40% |
Cash from operations | -37.06M | -99.65% |
Cash from investing | 29.22M | -7.76% |
Cash from financing | -215.00K | 85.01% |
Net change in cash | -8.05M | -168.93% |
Free cash flow | -24.08M | -127.10% |
About
Founded
2018
Headquarters
Website
Employees
112
